Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Essex Bio-Technology (01061.HK) spent HKD 10,300 to repurchase 5,000 shares on October 16.
16/10/2026
Zhitong Finance APP news, Essex Bio-Technology (01061.HK) announced that on October 16, 2026, it spent HK$10,300 to repurchase 5,000 shares.
Latest
2 m ago
*ST Konka A (000016.SZ) receives decision on termination of stock listing
3 m ago
China Beststudy Education Group (03978.HK) repurchased 95,000 shares for HKD 227,200 on October 16.
6 m ago
Jitai Co., Ltd. (002909.SZ) released its first three quarters results, with a net loss attributable to shareholders of RMB 7.6817 million.
7 m ago
Regarding the delisting of Alibaba's virtual human digital products, a person close to Alibaba Cloud stated that the delisting of the virtual digital human product is a normal removal due to strategic adjustment and product iteration. "The digital human market is currently very mature, and existing users are advised to migrate to related products such as Ant Lingjing Digital Human, Xiangxin Digital Human, and Yizhi Intelligent AI Live Streaming Digital Human." (Securities Times).
7 m ago
Harbour BioMed-B (02142.HK) repurchased 300,000 shares for HK$3.1494 million on October 16.
See all latest